13.09.2019
- Abbvie takes over Allergan, Pfizer merges its generics business with Mylan, Takeda integrates Shire — the pharmaceutical industry is making a name for itself in 2019 with several...
27.06.2019
- In a deal expected to close early next year, US biopharma AbbVie is buying troubled Botox manufacturer Allergan for $63 billion in cash and shares. The acquisition is the second...
05.04.2019
- Frankfurt / Weinheim, 03 April 2019. Seven companies from the chemical and pharmaceutical industries have been awarded the "Best Employer in Chemistry" prize as part of the new...
14.02.2019
- US biopharma AbbVie has agreed a deal with Teneobio, a California-based biotech, to develop and commercialize an immunotherapeutic that targets B-cell maturation antigen (BCMA) for...
26.11.2018
- US biopharma AbbVie has signed a deal with UK drug discovery and development group Mission Therapeutics to develop specific deubiquitylating enzymes (DUBs) for treating Alzheimer’s...
10.04.2018
- Biogen and partner Samsung Bioepis have reached agreement with AbbVie regarding the commercialization of Imraldi, their biosimilar form of the latter’s blockbuster Humira. Specific...
21.11.2017
- Boehringer Ingelheim has been granted its first biosimilar approval in Europe, receiving authorization to market Cyltezo for treating a variety of chronic inflammatory diseases in...
16.06.2017
- A federal jury in its home state of Illinois has ordered US drugmaker AbbVie to pay $15 million to cover current medical expenses and future care for a 10-year-old boy in...
